Abstract

AN OVERVIEW OF 3D PRINTING TECHNOLOGY: A CURRENT SCENARIO

Namrata Mahajan*, Apurva Parab, Mayur Shelar, Pooja Chauhan, Avantika Patil and Nitesh Mogaveera

Abstract

Three-dimensional printing [3DP], also known as additive manufacturing, is rapidly emerging as a transformative technology within the pharmaceutical industry. Its application in drug delivery systems has significantly expanded due to its ability to customize medications in precise, individually adjusted doses. By enabling the accurate deposition of medicaments and excipients, 3DP is poised to revolutionize drug formulation, production, and application, spanning the entire medication development process from preclinical stages to clinical trials and frontline healthcare. Beyond pharmaceuticals, 3D printers convert digital templates into tangible objects, layer by layer, utilizing a variety of materials such as plastic, metal, and nylon. This technology has proven beneficial across multiple sectors, including manufacturing, industrial design, aerospace, and medicine, offering a fast and cost-effective solution for diverse applications. The ongoing advancements in 3DP technologies continue to demonstrate their feasibility for commercial drug production, supported by regulatory assessments. In summary, 3D printing represents an exciting frontier in both drug delivery and broader manufacturing processes, with potential implications that extend well beyond its current applications.

Keywords: 3D Printing, Additive Manufacturing, Personalized Medicine, Drug Formulation, Pharmaceutical Innovation.